<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0012123'>Posterior uveitis</z:hpo> and <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:hpo ids='HP_0002633'>vasculitis</z:hpo> (RV) are the main causes of severe <z:hpo ids='HP_0000572'>loss of vision</z:hpo> or <z:hpo ids='HP_0000618'>blindness</z:hpo> in patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease (BD) </plain></SENT>
<SENT sid="1" pm="."><plain>Treatment of RV in BD is a difficult problem, because the agents are effective in <z:hpo ids='HP_0012123'>posterior uveitis</z:hpo> and ineffective in RV </plain></SENT>
<SENT sid="2" pm="."><plain>We observed 26 RV BD patients (20 men and 6 women aged 18-46 years, mean age 30.8 +/- 6.5 years), who were treated with <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> and <z:chebi fb="0" ids="35610">cytostatic</z:chebi> drugs </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="50858">Corticosteroids</z:chebi> were used by pulse therapy, orally, and locally (periocular injections) during the active period </plain></SENT>
<SENT sid="4" pm="."><plain>The results of pulse-therapy or oral <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> were better than of periocular injections (92.8, 90.9, and 45.5%, respectively, p &lt; 0.009) </plain></SENT>
<SENT sid="5" pm="."><plain>The velocity of reduction of <z:mp ids='MP_0001845'>inflammation</z:mp> and the degree of visual acuity improvement were better in the patients who received steroid pulse-therapy (12.7 +/- 2.4 and 0.19 +/- 0.21 days, respectively) in comparison with those who received oral steroids (17.7 +/- 1.8 days, p &lt; 0.000, and 0.08 +/- 0.07, p = 0.0121) </plain></SENT>
<SENT sid="6" pm="."><plain>A combination of <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> (200 mg/week intravenously) with <z:chebi fb="2" ids="8378">prednisolone</z:chebi> (10-15 mg/day) and cyclosporin (3.5 mg/kg/day) with <z:chebi fb="2" ids="8378">prednisolone</z:chebi> (10-15 mg/day) were effective for long control of RV BD patients </plain></SENT>
</text></document>